Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Hans Wadenvik

Reader

Hans Wadenvik
Reader
+46 31-342 1156

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Bruna stråket 5, vån5 , Göteborg


Department of Internal Medicine at Institute of Medicine (More Information)
SU Sahlgrenska
413 45 Göteborg
0313421000
Fax: +46 317863101
Visiting Address: Vita stråket SU , 413 45 Göteborg

Latest publications

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Andreas Hochhaus, Richard A Larson, François Guilhot, Jerald P Radich, Susan Branford et al.
The New England journal of medicine, Journal article 2017
Journal article

A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.
Michael Steurer, Philippe Quittet, Helen A Papadaki, Dominik Selleslag, Jean-François Viallard et al.
European journal of haematology, Journal article 2017
Journal article

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.
Stina Söderlund, Torsten Dahlén, Fredrik Sandin, Ulla Olsson-Strömberg, Maria Creignou et al.
European journal of haematology, Journal article 2017
Journal article

IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models.
Helena Ågerstam, Nils Hansen, Sofia von Palffy, Carl Sandén, Kristian Reckzeh et al.
Blood, Journal article 2016
Journal article

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.
N Gunnarsson, M Höglund, L Stenke, S Wållberg-Jonsson, F Sandin et al.
Leukemia, Journal article 2016
Journal article

Normalised immune expression in remission of paediatric ITP
Margareta Jernås, Frida Strömberg Celind, Intawat Nookaew, Karin Mellgren, Hans Wadenvik et al.
Thrombosis and Haemostasis, Journal article 2016
Journal article

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
Niklas Gunnarsson, Leif Stenke, Martin Höglund, Fredrik Sandin, Magnus Björkholm et al.
British journal of haematology, Journal article 2015
Journal article

Altered cytokine levels in pediatric ITP.
Margareta Jernås, Yu Hou, Frida Strömberg Celind, Linlin Shao, Qian Wang et al.
Platelets, Journal article 2015
Journal article

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study.
Mansoor N Saleh, James B Bussel, Gregory Cheng, Oliver Meyer, Christine K Bailey et al.
Blood, Journal article 2013
Journal article

Showing 1 - 10 of 128

2017

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Andreas Hochhaus, Richard A Larson, François Guilhot, Jerald P Radich, Susan Branford et al.
The New England journal of medicine, Journal article 2017
Journal article

A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.
Michael Steurer, Philippe Quittet, Helen A Papadaki, Dominik Selleslag, Jean-François Viallard et al.
European journal of haematology, Journal article 2017
Journal article

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.
Stina Söderlund, Torsten Dahlén, Fredrik Sandin, Ulla Olsson-Strömberg, Maria Creignou et al.
European journal of haematology, Journal article 2017
Journal article

2016

IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models.
Helena Ågerstam, Nils Hansen, Sofia von Palffy, Carl Sandén, Kristian Reckzeh et al.
Blood, Journal article 2016
Journal article

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.
N Gunnarsson, M Höglund, L Stenke, S Wållberg-Jonsson, F Sandin et al.
Leukemia, Journal article 2016
Journal article

Normalised immune expression in remission of paediatric ITP
Margareta Jernås, Frida Strömberg Celind, Intawat Nookaew, Karin Mellgren, Hans Wadenvik et al.
Thrombosis and Haemostasis, Journal article 2016
Journal article

2015

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
Niklas Gunnarsson, Leif Stenke, Martin Höglund, Fredrik Sandin, Magnus Björkholm et al.
British journal of haematology, Journal article 2015
Journal article

Altered cytokine levels in pediatric ITP.
Margareta Jernås, Yu Hou, Frida Strömberg Celind, Linlin Shao, Qian Wang et al.
Platelets, Journal article 2015
Journal article

2013

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study.
Mansoor N Saleh, James B Bussel, Gregory Cheng, Oliver Meyer, Christine K Bailey et al.
Blood, Journal article 2013
Journal article

Showing 1 - 10 of 128

Page Manager: Karin Allander|Last update: 8/23/2019
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?